112 related articles for article (PubMed ID: 14697287)
1. The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines.
Farivar RS; Gardner-Thorpe J; Ito H; Arshad H; Zinner MJ; Ashley SW; Whang EE
J Surg Res; 2003 Dec; 115(2):219-25. PubMed ID: 14697287
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors.
Cohen MS; Hussain HB; Moley JF
Surgery; 2002 Dec; 132(6):960-6; discussion 966-7. PubMed ID: 12490842
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S
Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349
[TBL] [Abstract][Full Text] [Related]
4. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
[TBL] [Abstract][Full Text] [Related]
5. The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor.
Graber M; June CH; Samelson LE; Weiss A
Int Immunol; 1992 Nov; 4(11):1201-10. PubMed ID: 1472473
[TBL] [Abstract][Full Text] [Related]
6. Genistein inhibits herbimycin A-induced over-expression of inducible heat shock protein 70 kDa.
Kiang JG
Mol Cell Biochem; 2003 Mar; 245(1-2):191-9. PubMed ID: 12708759
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a role of protein tyrosine kinases in cell death induced by gp120 in CHP100 neuroblastoma cells.
Russo R; Navarra M; Rotiroti D; Di Renzo G
Toxicol Lett; 2003 Apr; 139(2-3):207-11. PubMed ID: 12628756
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 10 modulation of tumour necrosis factor receptors requires tyrosine kinases but not the PI 3-kinase/p70 S6 kinase pathway.
Williams L; Lali F; Clarke C; Brennan F; Foxwell B
Cytokine; 2000 Jul; 12(7):934-43. PubMed ID: 10880238
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of stretch-induced increase in L-type calcium channel currents by herbimycin A in canine basilar arterial myocytes.
Kimura M; Obara K; Sasase T; Ishikawa T; Tanabe Y; Nakayama K
Br J Pharmacol; 2000 Jun; 130(4):923-31. PubMed ID: 10864901
[TBL] [Abstract][Full Text] [Related]
10. Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells.
Bagnato A; Tecce R; Di Castro V; Catt KJ
Cancer Res; 1997 Apr; 57(7):1306-11. PubMed ID: 9102218
[TBL] [Abstract][Full Text] [Related]
11. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats.
Blair HC; Jordan SE; Peterson TG; Barnes S
J Cell Biochem; 1996 Jun; 61(4):629-37. PubMed ID: 8806087
[TBL] [Abstract][Full Text] [Related]
12. Modulation of tyrosine kinase activity has multiple actions on insulin release from the pancreatic beta-cell: studies with lavendustin A.
Hisatomi M; Hayakawa T; Hidaka H; Niki I
Jpn J Pharmacol; 1997 Jun; 74(2):203-8. PubMed ID: 9243329
[TBL] [Abstract][Full Text] [Related]
13. Influence of the tyrosine kinase inhibitors STI571 (Glivec), lavendustin A and genistein on human mast cell line (HMC-1(560)) activation.
Löber K; Alfonso A; Escribano L; Botana LM
J Cell Biochem; 2008 Mar; 103(4):1076-88. PubMed ID: 17661356
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte stellation induced by tyrosine kinase inhibitors in culture.
Abe K; Saito H
Brain Res; 1999 Aug; 837(1-2):306-8. PubMed ID: 10434017
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway.
Chen CC; Sun YT; Chen JJ; Chiu KT
J Immunol; 2000 Sep; 165(5):2719-28. PubMed ID: 10946303
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitors of protein-tyrosine kinases: pharmacological perspectives?].
Jacquemin-Sablon A; Agbotounou WK; Pierre J
Pathol Biol (Paris); 1995 May; 43(5):389-94. PubMed ID: 8532375
[No Abstract] [Full Text] [Related]
18. Tyrosine kinase inhibitors suppress N-type and T-type Ca2+ channel currents in NG108-15 cells.
Morikawa H; Fukuda K; Mima H; Shoda T; Kato S; Mori K
Pflugers Arch; 1998 Jun; 436(1):127-32. PubMed ID: 9560456
[TBL] [Abstract][Full Text] [Related]
19. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Leduc I; Haddad P; Giasson E; Meloche S
Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of early response genes and cell proliferation through the human granulocyte macrophage colony-stimulating factor receptor: selective activation of the c-fos promoter by genistein.
Watanabe S; Muto A; Yokota T; Miyajima A; Arai K
Mol Biol Cell; 1993 Oct; 4(10):983-92. PubMed ID: 8298195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
